Reuters logo
BRIEF-Flex Pharma provides FLX-787 nocturnal leg cramp regulatory and clinical update
October 13, 2016 / 10:52 AM / in a year

BRIEF-Flex Pharma provides FLX-787 nocturnal leg cramp regulatory and clinical update

Oct 13 (Reuters) - Flex Pharma Inc

* Provides FLX-787 nocturnal leg cramp regulatory and clinical update

* Efficacy signals seen in subanalyses of exploratory human studies of FLX-787

* Parallel design phase 2 trial planned for first half 2017 based upon FDA pre-IND responses

* Says company is planning a parallel design phase 2 study in nlc to be initiated in first half of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below